Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Dow
McKesson
Medtronic
Colorcon

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Terbutaline sulfate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for terbutaline sulfate and what is the scope of patent protection?

Terbutaline sulfate is the generic ingredient in four branded drugs marketed by Novartis, Sanofi Aventis Us, Pharmacare, Akorn, Athenex Inc, Dr Reddys, Fresenius Kabi Usa, Hikma Farmaceutica, United Biomedcl, Ani Pharms Inc, Impax Labs, and Lannett Co Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for terbutaline sulfate. Ten suppliers are listed for this compound.

Drug Prices for terbutaline sulfate

See drug prices for terbutaline sulfate

Recent Clinical Trials for terbutaline sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Mississippi Medical CenterN/A
American University of Beirut Medical CenterPhase 3

See all terbutaline sulfate clinical trials

Medical Subject Heading (MeSH) Categories for terbutaline sulfate
Synonyms for terbutaline sulfate
(+-)-5-(2-((1,1-Dimethylethyl)amino)-1-hydroxyethyl)-1,3-benzenediol
(+-)-Terbutaline
031T256
031T325
1-(3',5'-dihydroxyphenyl)-2-(t-butylamino)-ethanol
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (9CI)
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-, (+-)-
1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-
2-t-Butylamino-1-(3,5-dihydroxyphenyl)ethanol
2-t-Butylamino-1-[3,5-dihydroxyphenyl]ethanol
23031-25-6
23031-32-5
23031-32-5 (Sulfate)
46719-29-3
5-(2-((1,1-DIMETHYLETHYL)AMINO)-1-HYDROXYETHYL)-1,3-BENZENEDIOL
5-(2-(tert-Butylamino)-1-hydroxyethyl)benzene-1,3-diol
5-(2-(tert-butylamino)-1-hydroxyethyl)benzene-1,3-diol hemisulfate
5-[2-(tert-Butylamino)-1-hydroxyethyl]-1,3-benzenediol #
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol, 5
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol,sulfuric acid
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol; sulfuric acid
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol;sulfuric acid
5-[2-(tert-butylamino)-1-oxidanyl-ethyl]benzene-1,3-diol
5-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}benzene-1,3-diol
A816514
AB00053548
AB00053548_15
AC-12158
AC1L1KA2
AC1L9AZM
AC1LCWBJ
ACM23031256
AKOS015889885
AKOS015909692
AKOS015960700
alpha-[(tert-butylamino)methyl]-3,5-dihydroxybenzenemethanol
API0005421
API0005740
Asthmasian (TN)
AX8152612
BCP09034
BDBM25770
Benzyl alcohol, .alpha.-((t-butylamino)methyl)-3,5-dihydroxy-
Benzyl alcohol, alpha-((t-butylamino)methyl)-3,5-dihydroxy-
bis(5-(2-(tert-butylamino)-1-hydroxyethyl)benzene-1,3-diol) sulfate
BPBio1_000663
BRD-A50157456-065-02-4
BRD-A50157456-065-12-3
Brethaire
Brethaire (Salt/Mix)
Brethine
Brethine (TN)
Brican
Bricanyl
Bricanyl (Salt/Mix)
Bricar
Bricaril
Bricyn
BRN 2370513
BSPBio_000601
BSPBio_002066
C07129
C24H40N2O10S
CAS-23031-32-5
CCG-205201
CCG-220391
CCG-222430
CCG-39265
CHEBI:9449
CHEBI:9450
CHEMBL1160544
CHEMBL1315867
CHEMBL1760
CPD001496939
CTK8E4128
CTK8G3346
D00688
D08570
DB00871
DivK1c_000078
DSSTox_CID_25437
DSSTox_GSID_45437
DSSTox_RID_80878
DTXSID3045437
DTXSID7021310
EINECS 245-385-8
EU-0101126
F2173-0944
FT-0654976
FT-0674863
GTPL560
HMS1569O03
HMS1921C15
HMS2092K19
HMS2096O03
HMS2231H10
HMS3259J05
HMS3263B13
HMS3372I16
HMS3713O03
HMS500D20
I01-3464
I14-31834
IDI1_000078
J-014950
KB-243251
KBio1_000078
KBio2_001510
KBio2_004078
KBio2_006646
KBio3_001566
KBioGR_001539
KBioSS_001510
KS-00001F8N
KWD 2019
KWD-2019
L000594
Lopac0_001126
LP01126
LS-29961
LS-7713
MFCD00079584
MLS000069693
MLS001148384
MolPort-003-959-699
NC00619
NCGC00016010-03
NCGC00016010-04
NCGC00016010-06
NCGC00016010-09
NCGC00016772-01
NCGC00089821-02
NCGC00094394-01
NCGC00094789-01
NCGC00094789-02
NCGC00094789-03
NCGC00094789-04
NCGC00261811-01
NINDS_000078
NSC-757336
NSC757336
Opera_ID_498
Oprea1_823972
PDSP1_000158
PDSP2_000157
Pharmakon1600-01500558
Prestwick_598
Prestwick0_000391
Prestwick1_000391
Prestwick2_000391
Prestwick3_000391
REGID_for_CID_657301
SAM002589944
SBI-0051094.P004
SCHEMBL26462
SCHEMBL41870
SCHEMBL4391
SMR000058516
SPBio_001453
SPBio_002522
Spectrum_001030
SPECTRUM1500558
Spectrum2_001327
Spectrum3_000593
Spectrum4_000870
Spectrum5_001262
SR-01000000174
SR-01000000174-2
SR-01000000174-4
SR-01000872654
SR-01000872654-1
sulfuric acid; bis(terbutaline)
T 2528
Terbutalin
Terbutalina
Terbutalina [DCIT]
terbutaline
Terbutaline (INN)
Terbutaline (sulfate de)
Terbutaline (sulfate)
Terbutaline [INN:BAN]
TERBUTALINE HEMISULFATE
Terbutaline hemisulfate salt
Terbutaline sulfate (JP17/USP)
Terbutaline sulfate (Salt/Mix)
Terbutaline sulfate, British Pharmacopoeia (BP) Reference Standard
Terbutaline sulfate, European Pharmacopoeia (EP) Reference Standard
Terbutaline sulfate, United States Pharmacopeia (USP) Reference Standard
Terbutaline sulfuric acid
Terbutaline,(+/-)
Terbutaline(sulfate)
Terbutalini sulfas
Terbutalino
Terbutalino [INN-Spanish]
Terbutalinum
Terbutalinum [INN-Latin]
Tox21_110602
Tox21_110602_1
Tox21_501126
TR-036208
V0238
VA11844
VU0244552-7
XWTYSIMOBUGWOL-UHFFFAOYSA-N

US Patents and Regulatory Information for terbutaline sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-002 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us BRICANYL terbutaline sulfate INJECTABLE;INJECTION 017466-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 077152-002 Mar 25, 2005 AB RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for terbutaline sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Baxter
Harvard Business School
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.